Exact Sciences (EXAS) continues to be impacted by escalating expenses and fierce competition.Exact Sciences has been grappling with escalated expenses for a while. Deteriorating international trade stemming from complex geopolitical environments across the globe is leading to a tough situation related to raw material and labor costs as well as freight charges. The stock carries a Zacks Rank #4 (Sell) currently.Further, the continuous rise in interest rates through 2023 with no news from the Fed of a rate cu ...